Open labelled multicenter randomized comparative trial of high-dose toremifene for non-steroidal aromatase inhibitor resistant breast cancer compared to exemestane.
Phase of Trial: Phase II/III
Latest Information Update: 21 Feb 2014
At a glance
- Drugs Toremifene (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 Sep 2012 Results presented at the 2012 Breast Cancer Symposium.
- 15 Sep 2012 Status changed from active, no longer recruiting to completed, based on presentation of results.
- 06 May 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.